Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Leukopenia and TP53[original query] |
|---|
| Phase I study of tirabrutinib (ONO-4059/GS-4059) in patients with relapsed or refractory B-cell malignancies in Japan. Cancer science 2019 3 110 (5): 1686-1694. Munakata Wataru, Ando Kiyoshi, Hatake Kiyohiko, Fukuhara Noriko, Kinoshita Tomohiro, Fukuhara Suguru, Shirasugi Yukari, Yokoyama Masahiro, Ichikawa Satoshi, Ohmachi Ken, Gion Naokazu, Aoi Arata, Tobinai Kens |
| Effect of XPD and TP53 Gene Polymorphisms on the Risk of Platinum-Based Chemotherapy Induced Toxicity in Bangladeshi Lung Cancer Patients. Asian Pacific journal of cancer prevention : APJCP 2021 12 22 (12): 3809-3815. Nairuz Tahsin, Bushra Yearul Umme, Kabir Year |
| Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2021 1 39 (14): 1584-1594. Sallman David A, DeZern Amy E, Garcia-Manero Guillermo, Steensma David P, Roboz Gail J, Sekeres Mikkael A, Cluzeau Thomas, Sweet Kendra L, McLemore Amy, McGraw Kathy L, Puskas John, Zhang Ling, Yao Jiqiang, Mo Qianxing, Nardelli Lisa, Al Ali Najla H, Padron Eric, Korbel Greg, Attar Eyal C, Kantarjian Hagop M, Lancet Jeffrey E, Fenaux Pierre, List Alan F, Komrokji Rami |
- Page last reviewed:Feb 1, 2024
- Content source: